Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

Share Price is delayed by 15 minutes
Get Live Data
465.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (0.108%)
Market Cap: £1.27b
CMCX Live PriceLast checked at - London Stock Exchange

Intraday CMC Markets Share Chart

Directorate change

3 Nov 2025 13:30

RNS Number : 9564F
CMC Markets Plc
03 November 2025
 

CMC MARKETS PLC("CMC Markets", the "Group" or the "Company")

3 November 2025

 

 

Appointment of Non-Executive Director

CMC Markets plc ("CMC Markets"), a leading global provider of online trading and investing businesses, is pleased to announce the appointment of Stuart Manning as a Non-Executive Director of the Company with effect from 1 November 2025. Stuart will also become Chair of the Group Audit Committee and a member of the Nomination, Remuneration and Risk Committees with effect from that date.

Stuart is a senior finance executive with more than 15 years' experience across venture capital, corporate finance, and regulatory supervision. He is currently Partner and Director of Finance (CFO) at Endeavour Vision SA, a Geneva-based private equity and venture capital firm focused on healthcare technology investments.

Prior to this, Mr Manning held roles at KPMG Ireland, where he worked across audit and corporate finance engagements for financial institutions.

Commenting on the appointment, Paul Wainscott, Chairman of CMC Markets, said:

"We are very pleased to welcome Stuart to the Board. His depth of experience in financial management, governance and risk oversight across the investment and regulatory sectors will be of great benefit to the Group as we continue to deliver on our strategy."

 

Regulatory Disclosures

There are no additional matters that require disclosure under UK Listing Rule 6.4.8 in respect of this appointment.

 

Enquiries:

Roy Tooley

Company Secretary

CMC Markets plc

Email: r.tooley@cmcmarkets.com

 

 

LEI: 213800VB75KAZBFH5U07

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFSLFDDEISEFF
Date   Source Headline
21st Nov 20247:05 amRNSDividend Declaration
21st Nov 20247:00 amRNSInterim Results
6th Nov 20243:29 pmRNSDirector/PDMR Shareholding
9th Oct 20249:42 amRNSDirector/PDMR Shareholding
9th Oct 20247:00 amRNSTrading Statement
9th Sep 20242:50 pmRNSDirector/PDMR Shareholding
3rd Sep 20244:13 pmRNSDirector/PDMR Shareholding
15th Aug 20243:07 pmRNSDirector/PDMR Shareholding
14th Aug 20244:15 pmRNSDirector/PDMR Shareholding
12th Aug 20249:25 amRNSDirector/PDMR Shareholding
6th Aug 20244:59 pmRNSDirector/PDMR Shareholding
25th Jul 20241:20 pmRNSResult of AGM
25th Jul 20247:00 amRNSQ1 2025 Trading Update
24th Jul 202410:42 amRNSDirector/PDMR Shareholding
10th Jul 202412:12 pmRNSDirector/PDMR Shareholding
8th Jul 20245:11 pmRNSDirector/PDMR Shareholding
24th Jun 20245:45 pmRNSNotice of AGM
20th Jun 20247:03 amRNSDividend Declaration
20th Jun 20247:03 amRNSDirectorate Change
20th Jun 20247:00 amRNSFinal results for the year ended 31 March 2024
7th Jun 202410:49 amRNSDirector/PDMR Shareholding
8th May 20243:10 pmRNSDirector/PDMR Shareholding
8th Apr 20243:12 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSFY 2024 Pre-Close Trading Update
6th Mar 20242:37 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:03 amRNSNotification Under Listing Rule 9.6.14
6th Feb 20245:08 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSCost reduction and efficiency plans
30th Jan 20249:37 amRNSDirector/PDMR Shareholding
16th Jan 20244:57 pmRNSDirector/PDMR Shareholding
8th Jan 202410:43 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSTrading Statement
6th Dec 20239:54 amRNSDirector/PDMR Shareholding
1st Dec 202312:54 pmRNSDirector/PDMR Shareholding
1st Dec 202312:49 pmRNSDirector/PDMR Shareholding
1st Dec 202312:41 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
7th Nov 20231:58 pmRNSDirector/PDMR Shareholding
6th Oct 20233:27 pmRNSDirector/PDMR Shareholding
25th Sep 202311:11 amRNSDirector/PDMR Shareholding
18th Sep 20232:48 pmRNSHolding(s) in Company
4th Sep 20237:00 amRNSAppointment of Chief Financial Officer
25th Aug 20237:00 amRNSTrading Statement
16th Aug 20231:52 pmRNSDirector/PDMR Shareholding
9th Aug 202312:13 pmRNSDirector/PDMR Shareholding
9th Aug 202312:11 pmRNSDirector/PDMR Shareholding
9th Aug 202312:10 pmRNSDirector/PDMR Shareholding
8th Aug 202310:00 amRNSDirector/PDMR Shareholding
27th Jul 20233:27 pmRNSResult of AGM
27th Jul 20237:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.